Citi raises target for Siemens Healthineers stock to EUR 47.00
Published on 10/15/2026 at 15:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view and reporting date
- Citi raised its Siemens Healthineers target from EUR 46.00 to EUR 47.00 on October 13, 2026.
- Siemens Healthineers is scheduled to report fourth-quarter results on November 5, 2026.
- Siemens Healthineers stock costs EUR 40.41 at Lang & Schwarz on October 15, 2026 at 3:08 p.m. CEST, plus 0.85 percent versus the Xetra close of October 14, 2026.
- Siemens Healthineers had a market capitalization of EUR 45.2 billion and a P/E ratio of 20.41.
Citi raised its Siemens Healthineers price target from EUR 46.00 to EUR 47.00 on October 13, 2026, while keeping a Buy rating, Markets Insider reports. Against the EUR 40.41 Lang & Schwarz price at 3:08 p.m. CEST on October 15, 2026, the new target is 16.31 percent higher. Siemens Healthineers was trading at EUR 40.41 at Lang & Schwarz on October 15, 2026 at 3:08 p.m. CEST, plus 0.85 percent versus the Xetra close of October 14, 2026.
Citi target reaches EUR 47.00
The analyst change gives the stock a clearly dated valuation reference without changing the current price picture. Citi lifted the target by EUR 1.00, or 2.17 percent, from EUR 46.00 to EUR 47.00. The target is 16.31 percent above the Lang & Schwarz price of EUR 40.41 on October 15, 2026.
Price range spans EUR 32.81 to EUR 49.71
The intraday picture was narrower than the full annual range. On October 15, 2026 at 3:00 p.m. CEST, Siemens Healthineers traded between EUR 40.00 and EUR 40.69, with 233,525 shares traded against an average volume of 908,942 shares. The 52-week range ran from EUR 32.81 to EUR 49.71, leaving the stock 18.71 percent below its high.
Valuation and November 5 date
Siemens Healthineers had a market capitalization of EUR 45.2 billion and a P/E ratio of 20.41 on October 15, 2026. Its next scheduled reporting date is November 5, 2026, when the company plans to publish fourth-quarter results and hold its analyst call, according to the Siemens Healthineers investor-relations page.
Comparison with peers
Siemens Healthineers: plus 0.85 percent, P/E 20.41, market capitalization EUR 45.2 billion
GE HealthCare Technologies (NYSE, USD): minus 0.47 percent, P/E 19.85, market capitalization USD 30.9 billion
DAX Performance Index (Germany, points): plus 0.02 percent, index level 25,257.80
Price and investor calendar
The stock remains below its 52-week high while the latest Citi target stands above the market price. The next company date is November 5, 2026, giving investors a defined calendar reference for the valuation discussion. The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.
Siemens Healthineers stock facts
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- Ticker: SHL
- Price Lang & Schwarz (as of October 15, 2026, 3:08 p.m. CEST): EUR 40.41
- Change versus Xetra close: plus 0.85 percent
- Xetra close (October 14, 2026): EUR 40.07
- Market capitalization: EUR 45.2 billion (as of October 15, 2026)
- 52-week range: EUR 32.81-49.71 (as of October 15, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: November 5, 2026
Market context: Market report DAX.
